Location via proxy:   [ UP ]  
[Report a bug]   [Manage cookies]                
Scribd Logo
Upload

Welcome to Scribd!

  • 23 views

    Parathyroid Drugs

    Uploaded by

    Amber LeJeune
    Parathyroid hormone and calcitonin are key hormonal regulators of bone mineral homeostasis. Teriparatide, a PTH analog, and calcitonin are used to treat osteoporosis when bisphosphonates have been ineffective or extreme bone loss or fractures have occurred. Vitamins D such as calciferol and calcitriol are also involved in calcium metabolism and bone formation. Bisphosphonates bind directly to hydroxyapatite crystals in bone to inhibit osteoclastic activity and bone resorption, and are used therapeutically to prevent fractures from osteoporosis. Calcium mimetic agents like cinacalet bind to calcium-sensing receptors on parathyroid chief cells

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd

    Parathyroid Drugs

    Uploaded by

    Amber LeJeune
    23 views2 pages
    Parathyroid hormone and calcitonin are key hormonal regulators of bone mineral homeostasis. Teriparatide, a PTH analog, and calcitonin are used to treat osteoporosis when bisphosphonates have been ineffective or extreme bone loss or fractures have occurred. Vitamins D such as calciferol and calcitriol are also involved in calcium metabolism and bone formation. Bisphosphonates bind directly to hydroxyapatite crystals in bone to inhibit osteoclastic activity and bone resorption, and are used therapeutically to prevent fractures from osteoporosis. Calcium mimetic agents like cinacalet bind to calcium-sensing receptors on parathyroid chief cells

    Copyright

    © © All Rights Reserved

    Available Formats

    PDF, TXT or read online from Scribd

    Did you find this document useful?

    Is this content inappropriate?

    Parathyroid hormone and calcitonin are key hormonal regulators of bone mineral homeostasis. Teriparatide, a PTH analog, and calcitonin are used to treat osteoporosis when bisphosphonates have been ineffective or extreme bone loss or fractures have occurred. Vitamins D such as calciferol and calcitriol are also involved in calcium metabolism and bone formation. Bisphosphonates bind directly to hydroxyapatite crystals in bone to inhibit osteoclastic activity and bone resorption, and are used therapeutically to prevent fractures from osteoporosis. Calcium mimetic agents like cinacalet bind to calcium-sensing receptors on parathyroid chief cells

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Download as pdf or txt
    23 views2 pages

    Parathyroid Drugs

    Uploaded by

    Amber LeJeune
    Parathyroid hormone and calcitonin are key hormonal regulators of bone mineral homeostasis. Teriparatide, a PTH analog, and calcitonin are used to treat osteoporosis when bisphosphonates have been ineffective or extreme bone loss or fractures have occurred. Vitamins D such as calciferol and calcitriol are also involved in calcium metabolism and bone formation. Bisphosphonates bind directly to hydroxyapatite crystals in bone to inhibit osteoclastic activity and bone resorption, and are used therapeutically to prevent fractures from osteoporosis. Calcium mimetic agents like cinacalet bind to calcium-sensing receptors on parathyroid chief cells

    Copyright:

    © All Rights Reserved
    Download as PDF, TXT or read online from Scribd
    Download as pdf or txt
    You are on page 1of 2

    PARATHYROID CA METABOLISMDRUGS

    HORMONAL REGULATORSOFBONEMINERALHOMEOSTASIS 2 HORMONALREGULATORSOFBONEMINERALHOMEOSTASIS


    JARATHYROIDHORMONE PARAFOLLICULAR
    THYROIDHORMONE
    teriparatide PTHanalog calcitonin

    parenteral Hdaypulsatile bone


    administration formation Marcel's thyroid secrete
    gland c alcitonin antagonize actions

    totreat
    used when
    osteoporosis ineffectivetextremebonelossloracturesocurred
    bisphosphonates

    other inhibit
    drugs
    osteoporosis bone this.esmuatesbonemmon
    resorption
    painassociatedwosteoporoticfracture
    relieves
    adverse
    effects useshypercalcemianotestine
    therapeutic

    term
    tolerancedevelops continuouslong
    use
    hypercalcemia nausea energy
    vomitingconstipation muscreweanness
    w of
    production anticalcitoninantibodies

    in adverse
    effects
    nasal
    spray rhinitis
    irritation nasal
    of mucosa
    VITAMINS D CALCIFEROLS epistaxis

    ergocalciferolvitD2
    cholecalciferol vitD3 flushing
    calcitriol HA
    paricalcitol test
    skin priortoinitiating totestforallergicran
    therapy

    calcipotriene limited warnings other


    efficacy safety options calcitoninno
    longerrecommended

    I Carpoyrenalexcretion
    I'CatPoyreabsorption OTHERS
    boneformation egg
    mum of
    usesp revention postmenopausalboneless
    therapeutic

    bileessentialforvito intestinalabsorption prevent


    osteoporosis riskorniporacture

    adverseeffects lastboneresorbingactionorpat
    hypercalcemia
    Triska
    hyperphosphatemia especially inptswrenalfailure breast
    cancer

    noteFGF23inhibitscalcitriolsynth Poy reabsorption endometrial


    cancer

    stone
    venousthromboembolism

    disease
    coronary

    SERMS Raloxifene
    linealternativeforpostmenopausalosteoporosisa intoleranttobisphosphonates
    first
    abone
    densitywloutanisnor cancer brisk
    endometrial breast
    invasive cancer

    glucocorticoids
    OTHERDRUGSAFFECTINGBONEMINERALHOMEOSTASIS

    BISPHOSPHONATES CALCIMIMETIC Agents


    alendronate2nd
    g eneration potency dayor ween cinacalet
    samidronate2nd
    g eneration impotencyoniyoneapprovedforivuseinpagets bindcasronchiefcellsinPTgland PTH
    inhibit secretion
    adverse
    effects
    bind tohydroxyapatite
    d irectly crystaisinbone stbonecensityrtfractures Nlrb
    hypercalcemia

    Tosteoclasticapoptosistosteoclasticactivity some
    inhibit
    farnesyl synthase
    pyrophosphate arthralgiamyalgia
    agents
    antiresorptive uses
    therapeutic

    uses
    therapeutic

    iiii
    disease
    Paget's 1 hyperparathyroidism duetoptadenomalcarcinoma

    of
    t reatment osteoporosis
    prevention

    inducedosteoporosis
    glucocorticoid

    hypercalcemia

    mm
    other
    bone
    diseasesw itboneresorption

    very oral
    poor bioavailability whentanenwlmeals

    drug
    manygood for
    interactions absorption takeonempty
    stomach 1hrbefore adverse
    effects
    remain
    breakfast upright30minprevent
    esophagitis donotgiveoraitobedriddenpts vivid

    tpoytptttdoesnottc .gg
    donotgiveto ptsw severerenalimpairmentsolelyrenallycleared dyspepsia

    adverse
    effects therapeutic
    of
    usesmanagement hyperphosphatemiainesropts

    diarrhea

    q
    erosion
    esophagealulceration
    gym
    osteonecrosisofjawcons sesp.nozoedronateontivaose monoclonalantibody Ravin
    against inhibit
    osteoclast
    formation stboneresorption

    IMHomo
    therapeutic usepostmenopausalosteoporosisinsultriskoffracture
    adverse
    effects

    nypocalcemi .osteonecrosisqjaw

    ns
    expensivelsz.ooo
    year administration
    fees e lectrolytes
    monitoring

    calcium
    phosphate

    You might also like